Category IP Policies

Idea Of A Multilateral Investment Court Makes Headway, Proponents Say

The European Union and Canada held an informal meeting in Geneva this week to present a project for a multilateral investment court to handle global investor-state disputes, hoping to draw interest and questions by other country delegates, according to sources. Time will be needed to gain acceptance of the idea, they said, and the next opportunity will be at the January World Economic Forum in Davos.

Things Heat Up In WIPO Debate On Patents And Health

The World Intellectual Property Organization patent law committee this week became the latest venue for the global debate over the system to provide incentives to the pharmaceutical industry to find new medicines while ensuring all patients have access to those medicines. Most developing countries want the committee to discuss the recommendations of the United Nations Secretary-General’s High-Level Panel on Access to Medicines, while most developed countries disagree. The tone is rising, and the issue could come as a hurdle as countries decide the future work of the committee.

USPTO Director Lee Discusses Importance Of Patent Quality

Opening a conference on patent quality today, United States Patent and Trademark Office Director Michele Lee highlighted efforts of the administration in improving the quality of patents and addressing backlog of patent applications. Patent backlog is down by one-third since the start of the Obama administration, she said.

EU, Canada Meet To Discuss A New Model For Investor-State Trade Disputes

The European Commission and the Canadian government today and tomorrow are hosting a first meeting for talks on a new multilateral investment court. Such a court could, the European Commission explained in an announcement, become the follow-up mechanism for the existing investor-state dispute settlement (ISDS) provisions that are part of 3,200 bilateral and multilateral free trade agreements around the world.

UAEM Targets Accessible Medicines, R&D Financing, Publicly Funded Research

From extracurricular creativity to global campaigns, Universities Allied for Essential Medicines (UAEM) continues in its activities to raise awareness and explore how universities can best direct their research and innovations towards promoting global access to medicines. In the next year, UAEM will extend its national and international campaigns to address the high prices of medicines, continue to gather support for a global agreement on research and development and build on the mapping alternative R&D initiatives.

A Look At The UNAIDS Board Debate On IP And Medicines; Outcome Fell Short For Some

The discussion on intellectual property-related barriers to access to medicines was one of the most contentious points of the 39th meeting of the UNAIDS governing board last week. After hours of negotiations, the board agreed that the organisation will keep working on the issue. But developing countries and civil society would have preferred a stronger mandate, according to representatives.